T. Rowe Price Investment Management, Inc. Morphic Holding, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 196,225 shares of MORF stock, worth $6.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
196,225
Previous 163,348
20.13%
Holding current value
$6.69 Million
Previous $4.72 Million
46.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$160 Million0.42% of portfolio
-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...